Ateronon
From Wikipedia, the free encyclopedia
Ateronon is a nutraceutical composed of lactolycopene, a combination of lycopene from tomato oleoresin and a whey protein matrix which increases the absorption / bioavailability of lycopene.[1][2]
A report containing data on Ateronon was presented at the British Cardiovascular Society Conference in June 2014.[3]
Studies
LactoLycopene has been used in numerous studies focused on lycopene bioavailability. A University of Cambridge study shows that lycopene levels in the blood rose between 60% and 100% within two months for people taking LactoLycopene, while another study at Boston's Brigham & Women's Hospital, run by Harvard Medical School, found that it increased average blood levels of lycopene at both six and 12 months.[4]
It has also been used to investigate the effects of lycopene on heart function [5][6] and male fertility.
A study at the Cleveland Clinic found that lycopene can boost sperm quality by up to 70 per cent,[7] while a team of researchers at the University of Sheffield found that LactoLycopene supplementation significantly increases the percentage of fast progressive sperm as well as normal and healthy sperm forms.[8]
History
Ateronon was developed by Cambridge Theranostics Ltd, UK, and launched in 2009.[9] The patent is currently held by its successor company, FutureYou Cambridge.
